Winner of the SunSafe Student Ambassador Program announced
11 December 2019
Belmont High School at Lake Macquarie has been announced winner of the 2019 SunSafe Student Ambassador Program video competition. Melanoma Institute Australia today attended the end of year assembly at Belmont High where they presented the award to students Brieanna Anderson, Alana Cross, Sophie Pilgrim and Amelia Velkouski and $1,000 in prize money for the school to use on sun safety initiatives.
The award is for the most powerful and engaging sun safety presentation given by student ambassadors to their peers at their schools, following their participation in MIA’s SunSafe Student Ambassador Program.
Six day-long sun safety and melanoma awareness sessions were run along the east coast of Australia in recent months. Of the 62 high schools which sent student representatives to participate, 44 submitted videos entries of their presentations delivered back at their schools. Muswellbrook High School in NSW was awarded 2nd place and Townsville Grammar School in QLD was awarded 3rd.
‘Our independent judging panel was blown away by the creativity and passion displayed in all the video entries,’ said Melanoma Institute Australia CEO Matthew Browne. ‘Belmont High’s presentation stood out due to its combination of humour, innovation and emotion to really engage students and generate behavioural change in terms of sun safety and melanoma prevention.’
The independent judging panel included Professor David Currow, Chief Cancer Officer of NSW; Associate Professors Matt Carlino and Robyn Saw who are both on Faculty at MIA; melanoma patients Craig Lawn, Natalie Fornasier and Jason Clare MP; and MIA major benefactor Kay Poche AO.
The Sun Safety Student Ambassador Program will return in 2020 and high schools can register their interest here: SunSafe Student Ambassador Program
Watch the winning video:
The 2021 Australasian Melanoma Conference (AMC2021) will held in Sydney, Australia.
Drug therapy set to become standard treatment in high-risk early stage patients to stop disease spread
We are excited to announce a return to our much-loved physical Melanoma March events in March 2022!
Over two fun, yet challenging, days in September an intrepid group of riders and crew successfully completed the annual Melanoma Bike Bash in WA!
Prof Long AO has been recognised by Australian Academy of Health and Medical Sciences for her transformative work advancing melanoma treatments.
Three MIA researchers at University of Sydney received grants to further their important melanoma research.
COVID restrictions continue to impact fundraising for melanoma services in Riverina.
Ben Garrow lost his life to melanoma. In his honour his family has established a scholarship to support a PhD student whose work focuses on saving lives from melanoma.
More than 150 clinicians, researchers and MIA staff gathered online to share research highlights.
Independent researchers at The University of Sydney are seeking patient feedback.
A re-cap of the wonderful, and often very creative, community fundraising initiatives over the April to June quarter.
Our patients who donate their tissue samples and records to our research are helping to make a difference to the lives of future melanoma patients.
MIA researchers have recently been awarded two competitive funding grants, which will help facilitate their ground-breaking work in melanoma research.
Celebrate the 10th anniversary of Amie St Clair Melanoma at the Annual Ball in Wagga Wagga!
Postponed to early 2022. Melanoma survivor Matt Kean is doing a 1000km bike ride around the Riverina to increase awareness of melanoma and raise funds for Amie St Clair Melanoma - MIA. There are many ways you can be part of this life-changing ride!
Riverina patients gain access to potentially life saving immunotherapy treatment close to home.
MIA's Prof Scolyer has been appointed as an Officer (AO) of the Order of Australia.
In a breakthrough which could extend to the treatment of other cancers, a new immune checkpoint inhibitor has proven effective in helping save the lives of advanced melanoma patients.
Whilst our research and clinical teams are trialling new treatments to save lives, it is our nurses who are on the front line providing care and support.